Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns

Expert Group On Antibiotic Susceptibility Testing [EGAST] 2008: A Non-Interventional, Multicenter In-Vitro Study To Evaluate The Prevalence Of Beta-Lactamase Producing Strains Among Clinical Isolates Obtained From Hospital In-Patients And Comparison Of Antimicrobial Susceptibility Using Disc-Diffusion Method

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00728624

Acronym

EGAST 2008

Enrollment

2039

Registered

2008-08-06

Start date

2008-11-30

Completion date

2009-09-30

Last updated

2017-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

Antibiotic susceptibility; beta lactamase; ESBLs

Brief summary

EGAST 2008 is a prospective, non interventional, multicentric study (approximately 2000 isolates from 15- 20 sites). Objectives: * Comparison of antimicrobial susceptibility using disc-diffusion method * Assessing prevalence of beta-lactamase producing strains among clinical isolates obtained from hospital in-patients

Detailed description

n/a n/a

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Isolates (as specified in the observational plan) from hospitalised patients

Exclusion criteria

Isolates obtained from outpatients will not be included for the study. Isolates from repeat cultures performed during in-patient follow-up that were previously recruited into the study will be excluded. Isolates identified as commensals or contaminants will be excluded

Design outcomes

Primary

Measure	Time frame
Comparison of antimicrobial susceptibility using disc-diffusion method	duration of trial

Secondary

Measure	Time frame
Assessing prevalence of beta-lactamase producing strains among clinical isolates obtained from hospital in-patients	duration of trial

Countries

India

Outcome results